Rock Springs Capital Management as of June 30, 2016
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 136 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Aetna | 4.0 | $54M | 440k | 122.13 | |
Acadia Healthcare (ACHC) | 3.4 | $46M | 837k | 55.40 | |
Tesaro | 3.2 | $44M | 520k | 84.05 | |
Allergan | 3.1 | $42M | 181k | 231.09 | |
Pfizer (PFE) | 2.8 | $37M | 1.1M | 35.21 | |
Hca Holdings (HCA) | 2.5 | $33M | 430k | 77.01 | |
Radius Health | 2.4 | $32M | 868k | 36.75 | |
Spark Therapeutics | 2.3 | $31M | 610k | 51.13 | |
Intuitive Surgical (ISRG) | 2.1 | $29M | 44k | 661.41 | |
Gilead Sciences (GILD) | 2.1 | $29M | 344k | 83.42 | |
Advanced Accelerat spon ads each rep 2 ord | 2.1 | $28M | 921k | 30.23 | |
Alexion Pharmaceuticals | 2.0 | $28M | 236k | 116.76 | |
CIGNA Corporation | 2.0 | $27M | 207k | 127.99 | |
WellCare Health Plans | 1.9 | $25M | 235k | 107.28 | |
Celgene Corporation | 1.9 | $25M | 255k | 98.63 | |
Gw Pharmaceuticals Plc ads | 1.8 | $25M | 270k | 91.57 | |
Medicines Company | 1.7 | $23M | 681k | 33.63 | |
Shire | 1.6 | $22M | 120k | 184.08 | |
Eli Lilly & Co. (LLY) | 1.6 | $22M | 276k | 78.75 | |
Teva Pharmaceutical Industries (TEVA) | 1.5 | $20M | 395k | 50.23 | |
Neurocrine Biosciences (NBIX) | 1.4 | $19M | 410k | 45.45 | |
Aclaris Therapeutics (ACRS) | 1.4 | $19M | 1.0M | 18.47 | |
HeartWare International | 1.3 | $18M | 311k | 57.75 | |
Pacira Pharmaceuticals (PCRX) | 1.2 | $16M | 473k | 33.73 | |
Theravance Biopharma (TBPH) | 1.2 | $16M | 700k | 22.69 | |
Thermo Fisher Scientific (TMO) | 1.1 | $15M | 100k | 147.76 | |
McKesson Corporation (MCK) | 1.1 | $15M | 78k | 186.65 | |
Bristol Myers Squibb (BMY) | 1.1 | $15M | 197k | 73.55 | |
Jazz Pharmaceuticals (JAZZ) | 1.1 | $14M | 102k | 141.31 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.1 | $14M | 1.2M | 11.85 | |
Penumbra (PEN) | 1.1 | $14M | 243k | 59.50 | |
Amgen (AMGN) | 1.1 | $14M | 94k | 152.15 | |
Mednax (MD) | 1.1 | $14M | 195k | 72.43 | |
Biogen Idec (BIIB) | 1.0 | $14M | 58k | 241.82 | |
Therapeuticsmd | 1.0 | $13M | 1.6M | 8.50 | |
Walgreen Boots Alliance (WBA) | 1.0 | $13M | 160k | 83.27 | |
Incyte Corporation (INCY) | 0.9 | $12M | 155k | 79.98 | |
Galapagos Nv- (GLPG) | 0.9 | $12M | 210k | 55.47 | |
Ardelyx (ARDX) | 0.8 | $11M | 1.3M | 8.73 | |
Prothena (PRTA) | 0.8 | $11M | 308k | 34.96 | |
Pra Health Sciences | 0.8 | $11M | 253k | 41.76 | |
Dermira | 0.8 | $10M | 355k | 29.25 | |
Healthsouth | 0.8 | $10M | 265k | 38.82 | |
Achillion Pharmaceuticals | 0.8 | $10M | 1.3M | 7.80 | |
Wright Medical Group Nv | 0.7 | $9.5M | 548k | 17.37 | |
Clearside Biomedical (CLSD) | 0.7 | $9.5M | 1.4M | 7.01 | |
Retrophin | 0.7 | $9.3M | 521k | 17.81 | |
BioMarin Pharmaceutical (BMRN) | 0.7 | $8.8M | 113k | 77.80 | |
XenoPort | 0.6 | $8.4M | 1.2M | 7.04 | |
Edwards Lifesciences (EW) | 0.6 | $8.3M | 84k | 99.72 | |
Alkermes (ALKS) | 0.6 | $8.4M | 195k | 43.22 | |
Hologic (HOLX) | 0.6 | $8.0M | 230k | 34.60 | |
Juno Therapeutics | 0.6 | $7.6M | 197k | 38.44 | |
Seres Therapeutics (MCRB) | 0.6 | $7.6M | 262k | 29.05 | |
Envision Healthcare Hlds | 0.6 | $7.4M | 291k | 25.37 | |
Intra Cellular Therapies (ITCI) | 0.6 | $7.4M | 190k | 38.82 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $7.4M | 86k | 86.02 | |
Ophthotech | 0.5 | $7.3M | 143k | 51.03 | |
American Renal Associates Ho | 0.5 | $7.2M | 250k | 28.97 | |
Corsicanto Ltd conv bnd | 0.5 | $7.2M | 7.0M | 1.03 | |
Ultragenyx Pharmaceutical (RARE) | 0.5 | $6.9M | 142k | 48.91 | |
Coherus Biosciences (CHRS) | 0.5 | $6.8M | 400k | 16.89 | |
Beigene (BGNE) | 0.5 | $6.7M | 225k | 29.80 | |
RTI Biologics | 0.5 | $6.7M | 1.9M | 3.59 | |
Corvus Pharmaceuticals (CRVS) | 0.5 | $6.4M | 450k | 14.26 | |
athenahealth | 0.5 | $6.3M | 46k | 138.01 | |
Five Prime Therapeutics | 0.5 | $6.3M | 153k | 41.35 | |
Invitae (NVTAQ) | 0.5 | $6.3M | 858k | 7.39 | |
Novavax | 0.5 | $6.2M | 853k | 7.27 | |
Adaptimmune Therapeutics (ADAP) | 0.5 | $6.2M | 765k | 8.15 | |
Hill-Rom Holdings | 0.5 | $6.1M | 120k | 50.45 | |
Epizyme | 0.5 | $6.1M | 598k | 10.24 | |
Cardiome Pharma | 0.5 | $6.1M | 1.2M | 5.12 | |
Macrogenics (MGNX) | 0.5 | $6.1M | 225k | 26.99 | |
Regeneron Pharmaceuticals (REGN) | 0.4 | $5.9M | 17k | 349.24 | |
Egalet Corporation note 5.50% 4/1/20 | 0.4 | $5.9M | 7.8M | 0.76 | |
Paratek Pharmaceuticals | 0.4 | $5.8M | 419k | 13.91 | |
Novadaq Technologies | 0.4 | $5.5M | 555k | 9.84 | |
Avexis | 0.4 | $5.4M | 143k | 38.02 | |
Compugen (CGEN) | 0.4 | $5.3M | 820k | 6.48 | |
CHINA CORD Blood Corp | 0.4 | $5.1M | 880k | 5.75 | |
Proteostasis Therapeutics In | 0.4 | $5.0M | 415k | 12.13 | |
Insmed (INSM) | 0.4 | $4.9M | 498k | 9.86 | |
Insys Therapeutics | 0.3 | $4.7M | 366k | 12.94 | |
Aduro Biotech | 0.3 | $4.7M | 415k | 11.31 | |
Tandem Diabetes Care | 0.3 | $4.5M | 595k | 7.54 | |
Alder Biopharmaceuticals | 0.3 | $4.5M | 181k | 24.97 | |
Intersect Ent | 0.3 | $4.4M | 340k | 12.93 | |
Portola Pharmaceuticals | 0.3 | $4.1M | 175k | 23.60 | |
Allergan Plc pfd conv ser a | 0.3 | $4.2M | 5.0k | 832.80 | |
Kite Pharma | 0.3 | $4.0M | 80k | 50.00 | |
Rigel Pharmaceuticals | 0.3 | $3.9M | 1.8M | 2.23 | |
Ascendis Pharma A S (ASND) | 0.3 | $4.0M | 300k | 13.27 | |
Otonomy | 0.3 | $3.8M | 240k | 15.88 | |
Amicus Therapeutics (FOLD) | 0.3 | $3.7M | 680k | 5.46 | |
Fibrogen (FGEN) | 0.3 | $3.7M | 225k | 16.41 | |
Auris Med Hldg | 0.3 | $3.6M | 850k | 4.19 | |
Endochoice Hldgs | 0.3 | $3.5M | 710k | 4.90 | |
Innoviva (INVA) | 0.3 | $3.5M | 337k | 10.53 | |
Medicines Company conv | 0.3 | $3.5M | 3.0M | 1.18 | |
Perrigo Company (PRGO) | 0.2 | $3.4M | 38k | 90.66 | |
Nabriva Therapeutics | 0.2 | $3.2M | 426k | 7.50 | |
Aimmune Therapeutics | 0.2 | $3.2M | 293k | 10.82 | |
Merus N V (MRUS) | 0.2 | $2.9M | 361k | 7.99 | |
Steris | 0.2 | $2.8M | 40k | 68.75 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $2.6M | 250k | 10.31 | |
Novocure Ltd ord (NVCR) | 0.2 | $2.5M | 214k | 11.67 | |
Aeglea Biotherapeutics | 0.2 | $2.5M | 524k | 4.86 | |
Sarepta Therapeutics (SRPT) | 0.2 | $2.5M | 131k | 19.07 | |
Dynavax Technologies (DVAX) | 0.2 | $2.4M | 165k | 14.58 | |
Dbv Technologies S A | 0.2 | $2.4M | 73k | 32.62 | |
Nivalis Therapeutics | 0.2 | $2.2M | 489k | 4.60 | |
Assembly Biosciences | 0.2 | $2.2M | 390k | 5.55 | |
Genocea Biosciences | 0.1 | $2.0M | 480k | 4.10 | |
Tetraphase Pharmaceuticals | 0.1 | $1.8M | 425k | 4.30 | |
Inovalon Holdings Inc Cl A | 0.1 | $1.9M | 104k | 18.01 | |
Clovis Oncology | 0.1 | $1.7M | 125k | 13.72 | |
Global Blood Therapeutics In | 0.1 | $1.6M | 98k | 16.59 | |
Dimension Therapeutics | 0.1 | $1.6M | 271k | 6.00 | |
Intercept Pharmaceuticals In | 0.1 | $1.4M | 10k | 142.70 | |
Egalet | 0.1 | $1.5M | 300k | 4.96 | |
Chiasma | 0.1 | $1.4M | 493k | 2.89 | |
Valeant Pharmaceuticals Int | 0.1 | $1.3M | 66k | 20.14 | |
Anthera Pharmaceutcls | 0.1 | $1.4M | 450k | 3.09 | |
Relypsa | 0.1 | $1.4M | 75k | 18.51 | |
Cerulean Pharma | 0.1 | $1.3M | 625k | 2.12 | |
Scynexis | 0.1 | $1.4M | 635k | 2.17 | |
Cerner Corporation | 0.1 | $1.2M | 20k | 58.60 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $1.2M | 434k | 2.78 | |
Sophiris Bio | 0.1 | $1.1M | 490k | 2.15 | |
Puma Biotechnology (PBYI) | 0.1 | $983k | 33k | 29.79 | |
Wright Med Group Inc note 2.000% 2/1 | 0.1 | $920k | 1.0M | 0.92 | |
Bluebird Bio (BLUE) | 0.1 | $866k | 20k | 43.30 | |
Orexigen Therapeutics | 0.1 | $711k | 1.7M | 0.43 | |
Mirna Therapeutics | 0.1 | $639k | 150k | 4.26 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $359k | 270k | 1.33 |